LYCOS RETRIEVER 
Pharmaceuticals: King Pharmaceuticals
built 606 days ago
King Pharmaceuticals has a well-recognized and highly prescribed portfolio of core-marketed products. Our leading brands include Avinza® CII, a once-daily morphine treatment for chronic pain; Skelaxin®, for relief from discomfort associated with acute musculoskeletal conditions; Thrombin-JMI®, which aids in controlling bleeding during surgery; Altace®, an ACE inhibitor; Sonata® CIV, one of three approved non-benzodiazepine treatments for insomnia; Levoxyl®, for the treatment of thyroid disorders; and Meridian Auto injector Products/EpiPen®. read more »
Source:
Manayer Najd Medical Co., a well known Agency in the field of pharmaceuticals, is the newest member among the ownership of Sheikh Mohamed Abd Al-Raheem Yassin. Manayer Najd is a company that markets, sells and distributes pharmaceuticals, medical supplies and cosmetics in Saudi Arabia. The staff at Manayer Najd has demonstrated great experience in the pharmaceutical market and will work hand in hand with APPI in order to penetrate the Saudi market. Manayer Najd will dedicate a sales and medical promotion team solely for the marketing of APPI products in the Kingdom. Manayer has achieved a trusted reputation amongst the old agencies in the Kingdom, and represents several foreign pharmaceutical companies in the territory.
Source:
King Pharmaceuticals, established in 1994, is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in specialty-driven markets including neuroscience hospital and acute care medicines. King has unique strengths in commercialization, advanced clinical development, manufacturing and regulatory affairs, which make the company a proven partner of choice for late stage compounds and novel branded prescription pharmaceutical products and technologies.
Source:
MORE ABOUT
King Pharmaceuticals